- SRx Health Solutions stock fell to a record low, marking a fifth consecutive session of declines after announcing a major business shift.
- The company plans to pivot from pet wellness products to a crypto-focused treasury platform through an acquisition of EMJ Crypto Technologies.
- The merger, led by activist investor Eric Jackson, still requires shareholder approval and is expected to close in the first quarter of 2026.
- Market skepticism has increased, with both public criticism and volatile retail investor sentiment following the news.
- Critics have raised concerns over the rapid transition and called for additional measures such as a reverse stock split.
Shares of SRx Health Solutions (SRXH) dropped 26% to close at $0.22 on Tuesday, extending their losses for a fifth straight trading session. The continued decline comes as investors evaluate the risks tied to the company’s abrupt strategy shift from selling pet wellness products to operating a cryptocurrency treasury platform.
In December, SRx Health Solutions, which rebranded from Better Choice Company earlier in the year, announced a definitive agreement to acquire EMJ Crypto Technologies (EMJX). The company intends to use Artificial Intelligence, quantitative models, and strict risk controls to manage a portfolio of crypto assets. If the reverse merger is finalized, Eric Jackson, founder and CEO of EMJX, will become the chairman and CEO of the newly combined company. The company’s board has approved the transaction, but final closing will require shareholder approval and is scheduled for the first quarter of 2026.
Following the initial announcement, the stock price briefly rallied to $0.61, giving the company a market valuation of about $8.4 million. However, the surge was short-lived, and shares have since declined as uncertainty weighed on investor confidence. Crypto-focused stocks often experience increased volatility due to fluctuations in Bitcoin prices and overall market sentiment.
On Tuesday, SRx Health reported that EMJX will expand its internal risk controls to include data from prediction markets such as Polymarket, improving assessments of regulatory and market risks in digital asset investments.
Additional pressure came after George Noble, a former associate of Peter Lynch, publicly criticized the transaction, describing it as “not just a merger, that’s a sinking ship.” As posted on X, Noble urged the company to consider a reverse stock split to provide more short-selling options.
EMJX aims to distinguish itself by actively managing a diversified crypto portfolio with hedging strategies, rather than depending on share dilution or passive asset exposure. Jackson has previously attracted retail investor attention through involvement in companies like Opendoor Technologies.
Retail users on Stocktwits showed mixed reactions and extremely high activity levels regarding SRx Health. One user stated, “Massive things being built. Everyone forgets Rome wasn’t built in a day?”, while another posted, “Fire the CEO now!!!” According to recent data, the stock has declined 26% so far in 2025.
For George Noble’s comments, see his post on X.
✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.
